Other analytes showed a trend of being highest in HD, then good outcome and lowest in bad outcome patient DC (CXCL13, eotaxin, IL-23, IL-31, IL-5, MCP-1, MIG, sCD40L, TIM3, TRAIL). This evidence concerns the gene CCL2 and Huntington disease.